F. Stelma

729 total citations
17 papers, 356 citations indexed

About

F. Stelma is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, F. Stelma has authored 17 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in F. Stelma's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (12 papers) and Immune Cell Function and Interaction (6 papers). F. Stelma is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (12 papers) and Immune Cell Function and Interaction (6 papers). F. Stelma collaborates with scholars based in Netherlands, Canada and United Kingdom. F. Stelma's co-authors include Hendrik W. Reesink, Neeltje A. Kootstra, A. de Niet, Ester M. M. van Leeuwen, R. Bart Takkenberg, Louis Jansen, Joanne Verheij, Karel A. van Dort, Klaas P. J. M. van Gisbergen and Sophie B. Willemse and has published in prestigious journals such as Hepatology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

F. Stelma

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Stelma Netherlands 11 224 193 127 52 37 17 356
Issam Tout France 12 299 1.3× 253 1.3× 103 0.8× 80 1.5× 41 1.1× 15 429
James Ahodantin France 8 170 0.8× 138 0.7× 58 0.5× 77 1.5× 24 0.6× 15 287
Louis Jansen Netherlands 12 369 1.6× 312 1.6× 63 0.5× 52 1.0× 43 1.2× 22 432
Marianne Eisenhardt Germany 8 203 0.9× 235 1.2× 247 1.9× 32 0.6× 12 0.3× 11 422
Koju Kobayashi Japan 11 206 0.9× 209 1.1× 85 0.7× 45 0.9× 9 0.2× 22 318
Mathieu Lefèvre France 6 177 0.8× 194 1.0× 51 0.4× 71 1.4× 18 0.5× 7 299
M Sidorkiewicz Poland 10 154 0.7× 217 1.1× 50 0.4× 93 1.8× 63 1.7× 29 337
Yongqian Cheng China 8 166 0.7× 143 0.7× 85 0.7× 53 1.0× 18 0.5× 19 286
Uta Zedler Germany 4 374 1.7× 269 1.4× 135 1.1× 64 1.2× 21 0.6× 4 438
John Yuen Hong Kong 9 414 1.8× 388 2.0× 43 0.3× 105 2.0× 12 0.3× 12 524

Countries citing papers authored by F. Stelma

Since Specialization
Citations

This map shows the geographic impact of F. Stelma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Stelma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Stelma more than expected).

Fields of papers citing papers by F. Stelma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Stelma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Stelma. The network helps show where F. Stelma may publish in the future.

Co-authorship network of co-authors of F. Stelma

This figure shows the co-authorship network connecting the top 25 collaborators of F. Stelma. A scholar is included among the top collaborators of F. Stelma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Stelma. F. Stelma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Niet, A. de, Louis Jansen, F. Stelma, et al.. (2022). A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients. Journal of Clinical and Experimental Hepatology. 12(3). 735–744. 9 indexed citations
2.
Stelma, F., Élise Roy, Patrice André, et al.. (2018). First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001. Journal of Hepatology. 68. S488–S489. 10 indexed citations
3.
Stelma, F., A. de Niet, Karel A. van Dort, et al.. (2017). Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity. Scientific Reports. 7(1). 6172–6172. 83 indexed citations
4.
Niet, A. de, Louis Jansen, F. Stelma, et al.. (2017). Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial. ˜The œLancet. Gastroenterology & hepatology. 2(8). 576–584. 36 indexed citations
5.
Ree, Meike H. van der, F. Stelma, Sophie B. Willemse, et al.. (2017). Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing. Antiviral Research. 146. 139–145. 13 indexed citations
6.
Stelma, F., Meike H. van der Ree, Anthony Brown, et al.. (2017). Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti‐MicroRNA‐122, RG‐101. Hepatology. 66(1). 57–68. 40 indexed citations
7.
Stelma, F., Sophie B. Willemse, A. de Niet, et al.. (2017). Dynamics of the Immune Response in Acute Hepatitis B Infection. Open Forum Infectious Diseases. 4(4). ofx231–ofx231. 14 indexed citations
8.
Stelma, F., Meike H. van der Ree, M. W. Peters, et al.. (2017). HBsAg loss after peginterferon‐nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow‐up. Journal of Viral Hepatitis. 24(12). 1107–1113. 21 indexed citations
9.
Stelma, F., Louis Jansen, Karel A. van Dort, et al.. (2016). HLA‐C and KIR combined genotype as new response marker for HBeAg‐positive chronic hepatitis B patients treated with interferon‐based combination therapy. Journal of Viral Hepatitis. 23(8). 652–659. 8 indexed citations
10.
Niet, A. de, F. Stelma, Louis Jansen, et al.. (2015). Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy. Journal of Hepatology. 64(3). 539–546. 32 indexed citations
11.
12.
Jansen, Louis, Andrew Vaillant, F. Stelma, et al.. (2015). O114 : Serum HBV-RNA levels decline significantly in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-CA. Journal of Hepatology. 62. S250–S250. 14 indexed citations
13.
14.
Stelma, F., Andrew Vaillant, Louis Jansen, et al.. (2015). P0659 : Cytokine responses in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-Ca. Journal of Hepatology. 62. S567–S567. 1 indexed citations
15.
Stelma, F., A. de Niet, Louis Jansen, et al.. (2015). P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir. Journal of Hepatology. 62. S498–S498. 1 indexed citations
16.
Jansen, Louis, A. de Niet, F. Stelma, et al.. (2014). HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels. Journal of Hepatology. 61(4). 730–737. 16 indexed citations
17.
Linssen, Catharina F. M., F. Stelma, Walther van Mook, et al.. (2006). Herpes simplex (HSV) viral load in bronchoalveolar lavage: risk factors and clinical outcome. Journal of Clinical Virology. 36. S9–S9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Issam Tout Breakdown of academic impact, for papers by James Ahodantin Breakdown of academic impact, for papers by Louis Jansen Breakdown of academic impact, for papers by Marianne Eisenhardt Breakdown of academic impact, for papers by Koju Kobayashi Breakdown of academic impact, for papers by Mathieu Lefèvre Breakdown of academic impact, for papers by M Sidorkiewicz Breakdown of academic impact, for papers by Yongqian Cheng Breakdown of academic impact, for papers by Uta Zedler Breakdown of academic impact, for papers by John Yuen
Rankless by CCL
2026